SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
69 hedge funds and large institutions have $154M invested in Syros Pharmaceuticals, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 14 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
31% less capital invested
Capital invested by funds: $224M → $154M (-$69.9M)
90% less call options, than puts
Call options by funds: $28K | Put options by funds: $267K
Holders
69
Holding in Top 10
2
Calls
$28K
Puts
$267K
Top Buyers
| 1 | +$6.81M | |
| 2 | +$1.97M | |
| 3 | +$876K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$316K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$285K |
Top Sellers
| 1 | -$1.67M | |
| 2 | -$1.53M | |
| 3 | -$1.06M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$975K |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$807K |